Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 5.17% | 20.24% | 50.58% | 48.86% | 65.38% |
| Total Depreciation and Amortization | 12.29% | 18.26% | 826.85% | 344.01% | 32.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.90% | -89.51% | -83.71% | -77.18% | -73.30% |
| Change in Net Operating Assets | 164.51% | 41.21% | 39.90% | 73.64% | 73.91% |
| Cash from Operations | -69.44% | -158.34% | -120.71% | -27.29% | 51.41% |
| Capital Expenditure | 29.95% | 37.17% | 9.34% | -326.43% | -97.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 84.42% | 84.43% | 84.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.39% | 4.81% | 86.94% | 85.76% | 88.97% |
| Cash from Investing | 164.38% | 55.46% | 70.18% | 55.75% | 62.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -38.90% | -21.95% | -49.82% | -49.82% | -50.32% |
| Repurchase of Common Stock | -26.47% | 58.96% | 56.47% | 42.51% | 69.91% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -10,639.47% | -10,639.47% | -129.53% |
| Cash from Financing | -21.38% | -32.89% | -60.98% | -61.06% | -74.74% |
| Foreign Exchange rate Adjustments | -173.45% | -118.36% | -19.30% | 1,145.24% | 1,068.38% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.49% | -2,011.09% | -65.58% | -24.62% | 32.39% |